【Major Events】Baima Tea (06980) will be open for subscription from October 20 to October 23, with a plan to globally issue 9 million H-shares, and is expected to list on October 28. Cambridge Technology (06166) is also set for subscription during the same dates, aiming to issue 67.0105 million H-shares, having secured cornerstone subscriptions of USD 290 million. Dipu Technology (01384) will offer 26.632 million H-shares for subscription from October 20 to October 23, with a listing anticipated on October 28. SANY Heavy Industry (06031) plans to issue 580 million H-shares from October 20 to October 23, having garnered cornerstone subscriptions of USD 758 million. Yuexiu Property (00123) successfully acquired a plot in Jing'an District, Shanghai through a consortium for RMB 7.737 billion. Kelun-Botai Pharmaceuticals (06990) announced multiple innovative drug research results at the 2025 European Society for Medical Oncology Congress. CanSino Biologics (09926) revealed the HARMONi-6 study results comparing Ivosidenib with Tazemetostat for first-line treatment of advanced SQ-NSCLC, published in The Lancet & presented at the 2025 ESMO. GFH375, a KRAS G12D inhibitor by Jintai Pharmaceuticals-B (02595), had its research data displayed at the 2025 ESMO annual meeting. The progress of JSKN003 by CanSino Biologics-B (09966) was presented in a poster at the 2025 ESMO Congress. CStone Pharmaceuticals (02171) presented the results of its Shurekio injection research at the 2025 ESMO meeting. Stone Pharmaceutical Group (01093) has been granted breakthrough therapy designation in China for JSKN 003 for treating HER2-positive advanced colorectal cancer. CanSino Biologics (09966) has again received CDE breakthrough therapy status. Yu-Long (02256) showcased long-term efficacy and safety data from the Phase III MANEUVER trial of Pemetrexed at the 2025 ESMO meeting. Galaxo Pharmaceuticals-B (01672) has completed US Phase IIa enrollment of a once-monthly subcutaneous depot form of GLP-1R agonist ASC30 for obesity treatment. 【Repurchases/Shareholding Adjustments】Leapmotor (09863) chairman and CEO Zhu Jiangming, along with shareholder Fu Liqian, increased their holdings by a total of 3.2435 million shares. Chalk (02469) saw its chairman Zhang Xiaolong acquire 810,000 shares, reflecting long-term confidence. Zhang Xiaolong and president Wei Liang of Chalk (02469) committed to not sell shares within 24 months. Midea Group (00300) repurchased 2.6164 million A-shares for RMB 190 million on October 20. SSSolar Control (02050) repurchased 429,300 A-shares for RMB 20.0118 million. China Communications Construction (01800) repurchased 114,760 A-shares for RMB 9.9997 million on the same day. 【Operating Results】CATL (03750) reported a net profit attributable to shareholders of approximately RMB 49.034 billion for the first three quarters, marking a year-on-year increase of 36.2%. Jinli Permanent Magnet (06680) posted a net profit attributable to shareholders of RMB 515 million for the first three quarters, up 161.81% year-on-year. China Mobile (00941) recorded a shareholder profit of RMB 115.4 billion in the first three quarters, a 4.0% year-on-year growth, with a net increase of 3.996 million mobile service subscribers in Q3. Yancoal (01171) achieved commercial coal production of 46.03 million tons in the third quarter, an increase of 4.92% year-on-year. China State Construction Industry (00830) reported operating revenue of approximately HKD 4.709 billion for the first three quarters, a decrease of 28.01% year-on-year. Huadian International Power (01071) completed total electricity generation of 201.33 million MWh for the first three quarters, approximately 5.87% lower year-on-year.